Education and Training
Imaging Kidney Transplant Rejection Using Ferumoxytol-Enhanced Magnetic Resonance
The goal of this study is to develop a non-invasive imaging test for in vivo detection of kidney transplant rejection. The hypotheses are that 1) Ferumoxytol-MRI can generate accurate estimates of tissue iron concentrations and tissue macrophages. 2) The signal given by a renal allograft on Ferumoxytol-MRI demonstrates significant differences between rejected and non-rejected transplants.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: Feraheme
- other: MRI-GE Healthcare 3 Tesla magnet
Eligibility
Inclusion Criteria:
- Completed solid organ transplant with referral for transplant follow-up
Exclusion Criteria:
- Exclusion criteria comprise MR-incompatible metal implants, need of sedation (since an
anesthesia is not supported by this), claustrophobia or hemosiderosis/hemochromatosis.
Ages Eligible for Study
8 Years - 40 Years
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Anne Sawyer
650-302-2846
Not Recruiting